ArticleBMC medicine2025
Machine learning-enhanced prediction of fetal growth restriction using fetal cardiac remodeling parameters.
Article in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Machine-Learning Models Outperform Clinicians in Predicting Postnatal Growth Failure Among Very Low Birth Weight Infants.Diagnostics (Basel, Switzerland) · 2026Article
- Current status and prospects of prenatal ultrasound diagnosis of congenital heart disease in fetuses: a narrative review.Translational pediatrics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFetal growth restriction (FGR) contributes to over 30% of late-pregnancy stillbirth, yet its diagnosis is challenging because current methods rely on indirect surrogate markers (estimated fetal weight and umbilical artery) that often fail to detect fetal compromise, particularly in late-onset cases. We hypothesized that fetal cardiac remodeling could provide a more robust basis for prediction. This study aimed to develop and validate the cardiac remodeling for FGR prediction model (CR-FGR), a first-in-class machine learning approach designed to operationalize the concept of fetal cardiac remodeling as a direct marker for FGR prediction.
methodsThis multicenter study of singleton pregnancies included retrospective development (n = 663) and prospective validation in two independent cohorts (internal, n = 224; external, n = 51). The primary outcome was FGR (birth weight < 10th percentile). From 938 echocardiography videos, 222 cardiac parameters were extracted. A machine learning process selected the five most predictive parameters for the final logistic regression model (CR-FGR): right ventricular stroke volume/kg (RVSV/kg), cardiac output/kg (RVCO/kg), cardiac output (RVCO), left ventricular cardiac output (LVCO), and end-systolic area (RVESA).
resultsThe CR-FGR model showed robust performance, with an area under the curve (AUC) of 0.872 (95% confidence interval (CI), 0.780-0.935) in the prospective internal testing set and 0.831 (95% CI, 0.674-0.947) in the external testing set. Its performance was comparable to a conventional EFW and Doppler model. Critically, the CR-FGR excelled in identifying challenging subgroups: it was highly effective for late-onset FGR (AUC 0.876, 95% CI, 0.748-0.951) and successfully detected FGR in many cases with normal umbilical artery Doppler, demonstrating its ability to capture pathology missed by traditional assessment.
conclusionsWe developed and validated the first machine learning model for FGR prediction based on fetal cardiac remodeling. This model establishes a new diagnostic strategy, offering a powerful, complementary tool that captures direct evidence of fetal compromise. It significantly enhances risk stratification, particularly for the clinically challenging late-onset and Doppler-normal phenotypes of FGR.
trial registrationThe Chinese Clinical Trial Registry, TRN: ChiCTR2000034182, Registration date: 27 June 2020.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.